Serogroups of Pseudomonas aeruginosa and the immune response of patients with cystic fibrosis.
about
Pseudomonas aeruginosa infection in cystic fibrosis: nucleotide sequence and transcriptional regulation of the algD geneMicrobial pathogenesis in cystic fibrosis: mucoid Pseudomonas aeruginosa and Burkholderia cepaciaAntigenic heterogeneity among pyocins of Pseudomonas aeruginosa.Agar-Gel Precipitating Antibody in Pseudomonas aeruginosa InfectionsAntiphagocytic Effect of Slime from a Mucoid Strain of Pseudomonas aeruginosaR-factor inheritance and plasmid content in mucoid Pseudomonas aeruginosa.Pseudomonas aeruginosa: immune status in patients with cystic fibrosisWhole, submandibular, and parotid saliva-mediated aggregation of Pseudomonas aeruginosa in cystic fibrosis.Inability of purified Pseudomonas aeruginosa exopolysaccharide to bind selected antibiotics.Cloning of genes controlling alginate biosynthesis from a mucoid cystic fibrosis isolate of Pseudomonas aeruginosa.Utilization of human respiratory secretions by mucoid Pseudomonas aeruginosa of cystic fibrosis origin.Genetic mapping of chromosomal determinants for the production of the exopolysaccharide alginate in a Pseudomonas aeruginosa cystic fibrosis isolate.Influence of mucoid coating on clearance of Pseudomonas aeruginosa from lungs.Alginate synthesis by Pseudomonas aeruginosa: a key pathogenic factor in chronic pulmonary infections of cystic fibrosis patients.Role of sialic acid in saliva-mediated aggregation of Pseudomonas aeruginosa isolated from cystic fibrosis patients.Longitudinal study of immune response to Pseudomonas aeruginosa antigens in cystic fibrosis.In vitro response of human T cells to Pseudomonas aeruginosaAntibody response to Pseudomonas aeruginosa exoproducts in cancer patientsPhenotypic differences among clinically isolated mucoid Pseudomonas aeruginosa strains.Serotypes and antibiotic susceptibilities of Pseudomonas aeruginosa isolates from single sputa of cystic fibrosis patients.Antibody response of patients with malignancies to bacteremia with gram-negative bacteria.Type-specific indirect hemagglutinating antibody in patients with Pseudomonas aeruginosa InfectionCystic fibrosis: a review of pulmonary infections and interventions.Pseudomonas aeruginosa infections.Intracellular killing of different strains of Pseudomonas aeruginosa by human leucocytes.Inhibition of human lymphocyte proliferation and cleavage of interleukin-2 by Pseudomonas aeruginosa proteases.Suppression of lymphocyte proliferation by Pseudomonas aeruginosa: mediation by Pseudomonas-activated suppressor monocytes.Genome fingerprinting of Pseudomonas aeruginosa indicates colonization of cystic fibrosis siblings with closely related strains.Pseudomonas aeruginosa: changes in antibiotic susceptibility, enzymatic activity, and antigenicity among colonial morphotypes.Protease phenotypes of Pseudomonas aeruginosa isolated from patients with cystic fibrosis.Production and characterization of the slime polysaccharide of Pseudomonas aeruginosa.Active immunization with lipopolysaccharide Pseudomonas antigen for chronic Pseudomonas bronchopneumonia in guinea pigs.The immune response of the host: an aid to etiology, pathogenesis, diagnosis, and epidemiology of bacterial infectionsTobramycin treatment of pseudomonas aeruginosa infections in cystic fibrosis.Does centralized treatment of cystic fibrosis increase the risk of Pseudomonas aeruginosa infection?
P2860
Q28493175-A45992CF-951F-4D09-A1D9-52B4AD08D652Q29615286-AF5A48B9-BCC3-4D0B-B87F-0EF7A36B3FB1Q34124998-E94EF771-CCE6-4A5B-9F75-D4D98717F00FQ34160925-19BD1F5D-2C99-4C27-912E-8E60016BEB9DQ34171211-723EADF8-CED9-4CE6-AA8C-3754A9A0AF7AQ34460990-7CB697F3-24F4-42B0-A362-449431971CEEQ34479437-2E1C9290-7CBC-4EB8-A019-13998F2E780AQ35094685-76B09295-0334-4442-93CC-D2C529793FD9Q35760463-D796BA98-93AC-479A-884C-659E93DFD228Q36301138-CF8324BA-AF6B-4B5C-A548-99490150E221Q36331443-823BA230-8759-4926-B4CA-B197701CBB5FQ36424054-B9BD2183-045D-421F-8308-1260B4C88FEEQ36446055-30B9273A-FAF6-4335-A685-9449AD422C6AQ36637394-128C40AA-9519-4E4F-A912-84DB013A0B93Q37023737-69C2B8F2-5815-4507-872C-ABD7DDA22780Q37103907-C024C3ED-5920-4533-8808-20C84A0DF517Q37112203-6DF8A979-CC74-4AE8-94B7-06AA6B646ED2Q37287848-C75EDE35-63FE-42CD-A5EE-A68512DA797BQ37299074-07C8E55B-D4C3-4C63-888C-E19CAC53A1B7Q37312309-617A9203-CE06-4481-A8D4-91CD35D99C3EQ37360975-49AF42B4-EDC8-403F-959D-533CDF1AB739Q39639978-77C3A0FF-6809-42B5-9164-A109DC2B9693Q39675635-1AE2E011-93B9-4EA5-9839-A2B5FBBED805Q39903765-3140B321-8316-4B45-9729-E6898634375EQ39953236-DCF5D04A-8383-4ECC-AED8-24FA71E594DEQ40158244-A7E13112-731D-463A-8072-D76464034F45Q40167110-93ED5183-5011-413D-9AE2-572FE21D0B99Q40196040-2C2F894A-E3E6-4ADC-84A2-12DD2415BBCFQ40223832-238CFEAC-96AE-46EC-9C7B-AE0D48D32010Q40225764-07172628-7CF9-42DB-8DD1-16CB1DA3EC8FQ40290468-77F82928-1432-44F0-9215-E06FDC640BE1Q40684350-87E1F073-67D2-49CB-871D-D83859973564Q41457662-FDB385BD-9AE0-4D16-AE10-97ECED59727EQ43431316-8DF89D8C-707C-416E-AFE1-CDE5D188242FQ44993011-70147059-98E3-49DC-A0AA-A9F6BEC6B21D
P2860
Serogroups of Pseudomonas aeruginosa and the immune response of patients with cystic fibrosis.
description
1970 nî lūn-bûn
@nan
1970年の論文
@ja
1970年学术文章
@wuu
1970年学术文章
@zh-cn
1970年学术文章
@zh-hans
1970年学术文章
@zh-my
1970年学术文章
@zh-sg
1970年學術文章
@yue
1970年學術文章
@zh
1970年學術文章
@zh-hant
name
Serogroups of Pseudomonas aeru ...... patients with cystic fibrosis.
@en
Serogroups of Pseudomonas aeru ...... patients with cystic fibrosis.
@nl
type
label
Serogroups of Pseudomonas aeru ...... patients with cystic fibrosis.
@en
Serogroups of Pseudomonas aeru ...... patients with cystic fibrosis.
@nl
prefLabel
Serogroups of Pseudomonas aeru ...... patients with cystic fibrosis.
@en
Serogroups of Pseudomonas aeru ...... patients with cystic fibrosis.
@nl
P2093
P921
P356
P1476
Serogroups of Pseudomonas aeru ...... patients with cystic fibrosis.
@en
P2093
P304
P356
10.1093/INFDIS/121.3.269
P407
P577
1970-03-01T00:00:00Z